Masimo Bridge™
Opioid Overdose Prevention / SUD
Commercial (FDA Breakthrough Device)Active
Key Facts
Indication
Opioid Overdose Prevention / SUD
Phase
Commercial (FDA Breakthrough Device)
Status
Active
Company
About Masimo
Masimo's mission is to improve patient outcomes and reduce the cost of care by innovating in non-invasive monitoring. The company achieved global leadership through its clinically superior SET® pulse oximetry platform and has since diversified into multi-parameter monitoring and hospital automation. Its current strategy focuses on expanding into new care settings (home, wearables) and leveraging its 2022 acquisition of Sound United to fuse consumer audio with health sensing technology.
View full company profile